Mologic has announced the opening of a US subsidiary and key appointments for its US and United Kingdom sites.
The firm announced Steve Fletcher as president and chief commercial officer of Mologic Inc. and head of the firm's US headquarters located just outside of Boston, Massachusetts.
Fletcher has more than 25 years of experience in leading marketing, product, and business operations for global healthcare companies, including 3M, Thermo Fisher Scientific, and GC America.
Mologic also appointed Tim Dwyer as its chief technology officer. Dwyer is a fellow of the Royal Society of Biology with more than 19 years of experience in the design and development of diagnostic devices on multiple immunoassay platform technologies.
The firm appointed Joseph Fitchett as its chief medical officer and head of global health to support the expansion of its UK facilities. In his previous role as a program officer at the Bill & Melinda Gates Foundation, Fitchett advanced the foundation’s bilateral partnerships with European Union donors, including advancing the manufacturing capacity of yellow fever vaccine and infectious disease surveillance and control, at the Institut Pasteur in Dakar.
In the US, Mologic also appointed Stephen Crossland as vice president of sales and business development and Andrew Wheeler as R&D manager.